Theiler's Virus Infection: a Model for Multiple Sclerosis
Top Cited Papers
Open Access
- 1 January 2004
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 17 (1) , 174-207
- https://doi.org/10.1128/cmr.17.1.174-207.2004
Abstract
SUMMARY: Both genetic background and environmental factors, very probably viruses, appear to play a role in the etiology of multiple sclerosis (MS). Lessons from viral experimental models suggest that many different viruses may trigger inflammatory demyelinating diseases resembling MS. Theiler's virus, a picornavirus, induces in susceptible strains of mice early acute disease resembling encephalomyelitis followed by late chronic demyelinating disease, which is one of the best, if not the best, animal model for MS. During early acute disease the virus replicates in gray matter of the central nervous system but is eliminated to very low titers 2 weeks postinfection. Late chronic demyelinating disease becomes clinically apparent approximately 2 weeks later and is characterized by extensive demyelinating lesions and mononuclear cell infiltrates, progressive spinal cord atrophy, and axonal loss. Myelin damage is immunologically mediated, but it is not clear whether it is due to molecular mimicry or epitope spreading. Cytokines, nitric oxide/reactive nitrogen species, and costimulatory molecules are involved in the pathogenesis of both diseases. Close similarities between Theiler's virus-induced demyelinating disease in mice and MS in humans, include the following: major histocompatibility complex-dependent susceptibility; substantial similarities in neuropathology, including axonal damage and remyelination; and paucity of T-cell apoptosis in demyelinating disease. Both diseases are immunologically mediated. These common features emphasize the close similarities of Theiler's virus-induced demyelinating disease in mice and MS in humans.Keywords
This publication has 517 references indexed in Scilit:
- Immune (dys)regulation in multiple sclerosis: role of the CD95–CD95 ligand systemImmunology Today, 1999
- Modulation of ICAM-1 Levels on U-937 Cells and Mouse Macrophages by Interleukin-1β and DexamethasoneBiochemical and Biophysical Research Communications, 1996
- Epidemiology of Multiple Sclerosis in Northwestern Sardinia: Further Evidence for Higher Frequency in Sardinians Compared to Other ItaliansNeuroepidemiology, 1995
- Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomasNature, 1995
- Interleukin-12 and its role in the generation of TH1 cellsImmunology Today, 1993
- Determinant spreading and the dynamics of the autoimmune T-cell repertoireImmunology Today, 1993
- Disruption of the murine IL-4 gene blocks Th2 cytokine responsesNature, 1993
- T cells: edited by Mark Feldmann, Jonathan Lamb and M.J. Owen, John Wiley and Sons, 1989. £73.85 (xi + 424 pages) ISBN 0 471 89169XImmunology Today, 1991
- The role of IL-10 in crossregulation of TH1 and TH2 responsesImmunology Today, 1991
- Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patientsNeurochemical Research, 1985